BlackRock Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.02M | Sell |
110,517
-21,638
| -16% | -$199K | ﹤0.01% | 2113 |
|
|
2016
Q3 | $1.56M | Buy |
132,155
+39,140
| +42% | +$461K | ﹤0.01% | 1770 |
|
|
2016
Q2 | $1.2M | Buy |
93,015
+1,976
| +2% | +$25.6K | ﹤0.01% | 1866 |
|
|
2016
Q1 | $1.46M | Sell |
91,039
-28,386
| -24% | -$454K | ﹤0.01% | 1715 |
|
|
2015
Q4 | $3.42M | Buy |
119,425
+108,244
| +968% | +$3.1M | ﹤0.01% | 1220 |
|
|
2015
Q3 | $318K | Buy |
11,181
+1,365
| +14% | +$38.8K | ﹤0.01% | 2367 |
|
|
2015
Q2 | $353K | Buy |
9,816
+3,340
| +52% | +$120K | ﹤0.01% | 2373 |
|
|
2015
Q1 | $189K | Buy |
6,476
+2,308
| +55% | +$67.4K | ﹤0.01% | 2505 |
|
|
2014
Q4 | $88K | Buy |
4,168
+140
| +3% | +$2.96K | ﹤0.01% | 2680 |
|
|
2014
Q3 | $78K | Sell |
4,028
-405,240
| -99% | -$7.85M | ﹤0.01% | 2606 |
|
|
2014
Q2 | $6.39M | Buy |
409,268
+227,220
| +125% | +$3.55M | ﹤0.01% | 1051 |
|
|
2014
Q1 | $3.77M | Sell |
182,048
-257,101
| -59% | -$5.33M | ﹤0.01% | 1210 |
|
|
2013
Q4 | $5.67M | Buy |
439,149
+50,652
| +13% | +$654K | ﹤0.01% | 1029 |
|
|
2013
Q3 | $4.53M | Sell |
388,497
-36,303
| -9% | -$423K | ﹤0.01% | 1091 |
|
|
2013
Q2 | $1.96M | Buy |
+424,800
| New | +$1.96M | ﹤0.01% | 1289 |
|